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Abstract
Brown adipose tissue has gained interest as a potential target to treat obesity and metabolic diseases. Irisin is a newly
identified hormone secreted from skeletal muscle enhancing browning of white fat cells, which improves systemic
metabolism by increasing energy expenditure in mice. The discovery of irisin raised expectations of its therapeutic potential
to treat metabolic diseases. However, the effect of irisin in humans is unclear. Analyses of genomic DNA, mRNA and
expressed sequence tags revealed that FNDC5, the gene encoding the precursor of irisin, is present in rodents and most
primates, but shows in humans a mutation in the conserved start codon ATG to ATA. HEK293 cells transfected with a human
FNDC5 construct with ATA as start codon resulted in only 1% full-length protein compared to human FNDC5 with ATG.
Additionally, in vitro contraction of primary human myotubes by electrical pulse stimulation induced a significant increase
in PGC1a mRNA expression. However, FNDC5 mRNA level was not altered. FNDC5 mRNA expression in muscle biopsies from
two different human exercise studies was not changed by endurance or strength training. Preadipocytes isolated from
human subcutaneous adipose tissue exhibited differentiation to brite human adipocytes when incubated with bone
morphogenetic protein (BMP) 7, but neither recombinant FNDC5 nor irisin were effective. In conclusion, our findings
suggest that it is rather unlikely that the beneficial effect of irisin observed in mice can be translated to humans.
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Introduction
Obesity and the involved risk of developing metabolic diseases
represent a major global public health challenge. In obese patients
glucose homeostasis is disturbed due to an imbalance between
energy intake and energy expenditure. Although the understand-
ing of the role of genetics in obesity and type 2 diabetes is
increasing [1–3], roughly 60% of all cases of diabetes can be
directly attributed to weight gain [4].
Brown adipose tissue (AT) has drawn attention as a novel
preventive and therapeutic target to treat obesity and metabolic
diseases like type 2 diabetes. Whereas white AT is the primary site
of triglyceride storage, brown AT is specialized in energy
expenditure. In order to maintain body temperature in a cold
environment, brown AT oxidizes fatty acids and generates heat [5]
by the mitochondrial uncoupling protein 1 (UCP1). Thus, UCP1
knock-out mice are cold sensitive and tend to develop obesity, even
when fed a control diet [6], whereas experimental approaches
aiming to increase the amount and activity of brown AT reduce
the development of obesity [7]. Brown AT has also been detected
in humans and is found in anatomically discrete depots, with the
most common location in adults in the cervical-supraclavicular
depot [8–12].
Brown adipocytes and skeletal muscle cells arise from progen-
itors expressing myf5 [13] and their differentiation is specifically
controlled by transcriptional regulators like PRDM16 [14], PGC1a
[15], and others [16–19]. Chronical stimulation of mouse
preadipocytes derived from epididymal white AT with rosiglita-
zone, a PPARc agonist, reveals a thermogenic competent
population of UCP1-expressing adipocytes [20]. These cells do
not represent classical brown adipocytes, because they do not
express typical brown AT transcription factors such as ZIC1 and
PRDM16. Instead, these cells appear to be a particular type of
adipocytes termed as ‘brite’ (brown-in-white) adipocytes. Thus, the
possibility to switch from white AT to brite AT and to identify
mechanisms that can activate white to brown trans-differentiation
in response to pharmacological compounds is highly attractive in
the context of obesity treatment.
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Bostro¨m et al. published a promising mechanism for the
induction of brite adipocytes in white AT depots after exercise
in mice. Overexpression of PGC1a in mice skeletal muscle as well
as exercise induced expression of the FNDC5 gene [21], a gene
which has scarcely been studied before. In 2002 two different
groups first described the mouse sequence of FNDC5 [22,23]. In
adult murine tissues, FNDC5 is highly expressed in heart and brain
and less in skeletal muscle [22,23]. FNDC5 is described as a
protein containing a signal peptide, fibronectin type III repeats,
and hydropathy analysis revealed a hydrophobic region, which is
likely to encode a transmembrane domain. Previous studies linked
the gene to differentiation of myoblasts and neurones [23,24], and
it has been suggested that FNDC5 is located in the matrix of
peroxisomes [23]. However, Bostro¨m et al. showed that the
transmembrane protein is cleaved by transfected HEK293 cells
and the extracellular part of the protein is released, which acts as
novel molecule called irisin [21]. Viral delivery of FNDC5 in mice
caused browning of subcutaneous fat, stimulated oxygen con-
sumption, and diminished diet-induced weight gain and metabolic
dysfunction [21]. Thus, irisin induced a thermogenic mechanism
in white AT, which improved whole body energy balance in mice.
This initial report of irisin linked the FNDC5 gene to browning in
mice.
Furthermore, Bostro¨m et al. were the first to describe this gene
in humans [21]. The bioinformatics analysis of the FNDC5 gene
performed by us revealed that divergent sequences have been
published. Until the protein sequence was modified September 5,
2012 the UniProt database entry FNDC5/Q8NAU1 represented
the full-length protein as described by Bostro¨m et al. [21]. The
UniProt entry was modified, since the underlying transcript
sequence was classified as artefact. Now, two potential protein
sequences are available at the UniProt database. Ivanov et al.
described human FNDC5 as a gene with a mutation in the start
codon to ATA [25], encoding isoleucin, instead of ATG, encoding
methionine. Using this non-canonical start site would generate the
full-length protein. The translation of the second protein sequence
starts at the first in-frame ATG start codon of the FNDC5 ORF,
but as this ATG is located 76 codons downstream the resulting
protein would be a truncated irisin protein.
Although, the initial description of irisin was focused on mice,
Bostro¨m et al. raised the hope that exogenously administered irisin
might have a therapeutic potential in the treatment of obesity and
diabetes in humans. Thus, the aim of our present study was to
analyze the human FNDC5 gene and to explore its function in the
human system. Our findings indicate that great caution is needed
when extrapolating data regarding FNDC5/irisin from rodent to
the human situation.
Results
Start Codon of FNDC5 Gene is Mutated in Humans
A multi-species sequence alignment of the FNDC5 exon 1
demonstrated that FNDC5 genes from different species like rat,
mouse, gibbon, gorilla and chimp display a conserved ATG
translation start site, except for the human sequence (Figure 1A).
In contrast, at the position of the start codon the human sequence
shows an ATA, encoding isoleucin (I), instead of the conserved
ATG, encoding methionine (M). Using 59-RACE-PCR, we could
confirm experimentally the mutation within the start codon as
ATA in human brain and skeletal muscle samples (Figure S1).
According to the current UniProt entry Q8NAU1 (Figure 1B,
FNDC5_human_c) this is potentially a non-canonical start site and
could still produce to full-length FNDC5, which might be later
proteolytically cleaved to release irisin.
Before translation start, the ribosome recognizes a conserved
mRNA sequence as the start site for protein translation, called
Kozak consensus sequence (GCCXCCATGG, X=A or G).
However, Kozak et al. showed that a mutated start codon to
ATA, even in a perfect context (GCCXCCATAG, X=A or G,
Figure 1A), was highly unlikely to serve as a translation site and
resulted in low translation efficiency [26]. The next in-frame
downstream ATG (M, marked in red in Figure 1B) is a non-Kozak
ATG and located within the sequence that was annotated as irisin
(irisin sequence marked in blue, Figure 1B). Thus, an N-terminal
truncated FNDC5 (represented by cDNA sequences NP_ 715637/
NM_153756) and truncated irisin would be generated. In addition
there are three upstream partial Kozak ATGs in this mRNA that
are not in frame with the FNDC5 open reading frame (ORF) and
would therefore strongly reduce translation from this new start site
(Figure S3). It has been experimentally shown that the translation
efficiency of non-canonical sites can be increased, if a hairpin slows
down the scanning ribosome [27], as described for FGF2 (Figure
S4A). Based on this observation, an ATG hairpin program
predicts if there are stem-loop structures in an appropriate
distance to the ATA [28], which would increase the translation
efficiency. However, for human FNDC5 no eligible hairpin
structures were found (Figure S4B).
A comparison of the full-length human FNDC5 protein
sequence published by Bostro¨m et al. (Figure 1B, FNDC5_hu-
man_o, [21]) with mRNA, expressed sequence tags, genomic
DNA and single-nucleotide polymorphism data revealed that the
first three amino acids (MRR, Figure 1B) do not match human
genomic DNA. We excluded that this is due to differential splicing,
because 20 expressed sequence tags and two Ref_Seq cDNAs that
cover this region, perfectly matched the annotated exon 1 region
(Figure S2). We analyzed public single-nucleotide polymorphism
data, but could not find a reference that this codon might be
altered.
Full-length Human FNDC5 with ATA as Start Codon is not
Translated into Protein
Nevertheless, FNDC5 mRNA is expressed in human tissues,
predominantly in the heart, less in muscle and brain (Figure S5). In
certain cases, translation initiation can occur at codons differing
from ATG by a single nucleotide, like ATA [25]. To verify
whether human FNDC5 was translated into full-length protein
with a non-ATG initiation, the human gene was cloned into the
expression vector pcDNA5-FRT TO-cEGFP. In addition to this
vector with ATA as start codon (ATA-hFNDC5-GFP), a second
vector with ATG as classical start codon (ATG-hFNDC5-GFP)
(Figure S6) and as a control murine FNDC5 (mFNDC5-GFP) was
cloned. All vectors were transfected into HEK293 cells.
Although transient transfection of HEK293 cells with the
expression vectors of mFNDC5-GFP and ATG-hFNDC5-GFP
resulted in a clearly detectable fluorescence signal due to the
expression of GFP-FNDC5 fusion protein, most importantly, for
ATA-hFNDC5-GFP transfected cells the signal was hardly
detectable (Figure S7A, B).
Analysing the protein level of transfected HEK293 cells
revealed that the human construct with ATG as start codon
produced similar amounts of full-length protein compared to
murine FNDC5. The protein can be detected in two distinct bands
of 52 and 56 kDa as shown by western blot analysis (Figure 2B).
Full-length FNDC5 protein seems to be glycosylated, because
incubation of cell lysates with N-glycosidase F (PNGase F) resulted
in merging of the two bands into one signal with a significantly
decreased size of 48 kDa. In contrast, the human transcript with
ATA as start codon resulted only in 1% full-length protein as
Irisin Has No Effect in Humans
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Figure 1. The human FNDC5 gene differs from other species by a mutation in the start codon. (A) Multiple alignment of the exon 1
sequences: the conserved partial Kozak ATG start sequence of FNDC5 is bold and red. The mutated ATG to ATA in human is bold and blue. There is
no other ATG present in exon 1. (B) Multiple sequence alignment of FNDC5 proteins of different species including two human versions.
FNDC5_human_o: sequence published by Bostro¨m et al.; FNDC5_human_c: current version in Uniprot; red M = start methionines including the
potential downstream human start site; light blue = irisin sequence; blue I = mutated start site claimed to be a non canonical start site; purple
LRL = sequence shown in UniProt (Q8NAU1_old) as MRR. The underlined sequence indicates the transmembrane part of the protein. Green
sequence = peptide used for the generation of the Abcam FNDC5 antibody.
doi:10.1371/journal.pone.0073680.g001
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compared to ATG-hFNDC5-GFP. Instead the downstream in-
frame ATG (represented by NP_715637, starting with MLRFI-
QEVN, Figure 2A (b)) was translated into a protein missing the
first 76 amino acids. However, this ATG was used with strongly
reduced efficiency and was apparently not glycosylated.
Additionally, at a molecular size of 36 kDa a very weak band
was detected possibly representing the second downstream ATG
of human FNDC5 (aa131) or murine FNDC5 (aa128), (Figure 2A
(c), starting with MASKNKDE, Figure 1B).
A comparison of the irisin protein levels released by differen-
tiated primary human skeletal muscle cells compared to murine
Figure 2. Human FNDC5 with an ATA start codon is translated into full-length protein only at very low abundance. (A) Schematic
representation of the predicted FNDC5 protein structures. Using the first ATG/ATA as start codon of human FNDC5 tagged with GFP would result in
full-length FNDC5 protein (a). The use of downstream ATG as start codon would result in truncated FNDC5 protein isoforms (b and c). Murine FNDC5
with ATG as start codon tagged with GFP (d) or without GFP (e). (B) Expression of FNDC5 in HEK293 cells. Cells transfected with constructs containing
human FNDC5-GFP gene with ATA and ATG as start codon as well as mouse FNDC5-GFP gene were analyzed 24 h after transfection. Cell lysates were
analyzed by immunodetection using antibodies against irisin/FNDC5 and GFP. Cell lysates were treated with PNGaseF to deglycosylate proteins. (C)
Supernatants of primary human and C2C12 myotubes were collected for 24 h in serum-free medium and concentrated 60fold using centrifugal filter
devices. Irisin protein levels in concentrated supernatants were measured using EIA kit. Medium alone showed no cross-reactivity with the kit; n = 5,
*** p,0.001.
doi:10.1371/journal.pone.0073680.g002
Irisin Has No Effect in Humans
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C2C12 cells showed substantially lower irisin protein levels in the
supernatant of human cells compared to murine cells (Figure 2C).
FNDC5 Gene is not Activated by Contraction in Humans
PGC1a gene expression is induced in muscle by exercise [29]
and FNDC5 gene expression was reported to be PGC1a-dependent
in mice [21]. To study contraction-regulated gene expression, we
previously developed an in vitro contraction model using electrical
pulse stimulation (EPS) of primary human skeletal muscle cells
[30]. By using this EPS model, PGC1a mRNA expression was
significantly enhanced after 24 h of EPS in primary human
skeletal muscle cells (1.5fold, Figure 3A). However, FNDC5 mRNA
expression was not altered (Figure 3A). This EPS-protocol,
induced a significant upregulation of MYH7 mRNA level
(encoding myosin heavy chain (MHC) isoform 1 protein, 1.6fold),
while MYH2 (encoding MHC2a) and MYH1 (encoding MHC26)
were unaltered (Figure 3B).
The gene expression of FNDC5 in human muscle biopsies was
examined before and after extensive and documented training in
two different cohorts. We found no FNDC5 gene activation by
neither 10 weeks of interval endurance training among 4162 years
old males (Figure 3C) nor 11 weeks of strength training in 2864
years old males with normal body weight (Figure 3D).
Recombinant FNDC5 and Irisin have No Effect on the
Brite Differentiation of Human Preadipocytes
We isolated preadipocytes from primary human subcutaneous
AT and differentiated these cells to mature adipocytes in the
presence of recombinant FNDC5 (200 ng/ml), irisin (60 ng/ml) or
BMP7 (50 ng/ml) as a positive control, respectively. FNDC5 was
obtained from Abnova, which also was used by Bostro¨m et al. [21]
and Wu et al. [31]. In addition, we used recombinant FNDC5
protein obtained from Phoenix.
BMP7 potently induced a brite gene program in cultured
adipocytes. Incubation with BMP7 during differentiation induced
an increased expression of the general differentiation marker for
adipogenesis PPARc (3.6fold) (Figure 4A). Notably, UCP1, known
as a brite marker, was even stronger enhanced (6.4 fold, Figure 4A).
Additionally, the mRNA expression of TCF21 [20], a marker for
white AT, was significantly reduced after BMP7 incubation
(Figure 4A). ZIC1 is a marker for classical brown AT of myogenic
origin in mice [20] and its expression was unaltered after BMP7
incubation of human adipocytes (Figure 4A). Neither recombinant
FNDC5 nor irisin had an effect on mRNA expression of PPARc,
UCP1, TCF21 or ZIC1 (Figure 4A).
In addition to UCP1, the transcription factor PGC1b, which
regulates mitochondrial biogenesis, and CYCS (cytochrome c), an
electron carrier protein of the mitochondrial electron transport
chain, were both significantly enhanced by incubation with BMP7
(Figure 4B), while FNDC5 and irisin did not alter the mRNA level
of these targets. Even higher concentrations of recombinant
Figure 3. FNDC5 mRNA level is not contraction-regulated in skeletal muscle cells and is not increased by endurance or strength
training in humans. (A) and (B) Primary human skeletal muscle cells were differentiated in aMEM containing 2% (vol./vol.) horse serum, followed by
overnight starvation, and subjected to EPS for 24 h in serum-free medium (1 Hz, 2 ms, 11.5 V). Relative gene expression of PGC1a, FNDC5 (A), MYH1,
2, and 7 (B) was measured by quantitative real-time PCR (qRT-PCR). All expression data were normalized to actin; n = 5 (A), n = 10 (B); **p,0.01. White
bars, control (non-EPS); black bars, EPS. (C) qRT-PCR analysis of FNDC5 expression in m. vastus lateralis from young sedentary males before (Pre) and
after 10 weeks (Post) of aerobic interval training (n = 6). (D) qRT-PCR analysis of FNDC5 expression in m. trapezius from sedentary males before (Pre)
and after 11 weeks (Post) of strength training (n = 7). All expression data were normalized to RPLP0. Data are presented as mean values 6 SEM.
doi:10.1371/journal.pone.0073680.g003
Irisin Has No Effect in Humans
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FNDC5 (1000 ng/ml) and irisin (600 ng/ml) as well as recombi-
nant irisin obtained from a second company (Cayman Chemical,
60 and 600 ng/ml) had no effect on UCP-1 and PPARc mRNA
level (Figure S8).
The most prominent effect on UCP1 mRNA expression was
observed in cells highly expressing CD137, a novel recently
described marker of preadipocytes which are susceptible to
browning [31] (Figure 4C, D). Our present study includes
experiments with adipocytes of more than 10 different donors.
Analyzing expression of CD137 on day 0 revealed that the donors
may be clustered in a CD137-low expressing and a CD137-high
expressing group (Figure 4C). CD137-high expressing adipocytes
were more sensitive to BMP7-induced brite differentiation, as
indicated by a higher UCP1 induction compared to the expression
of the general differentiation marker PPARc (Figure 4D). In
marked contrast to the gene activation by BMP7, no effect of
FNDC5 and irisin on classical brown and brite AT markers could
be observed (Figure 4A, B). The CD137 expression level had no
impact on the FNDC5 response of adipocytes (Figure 4D).
Moreover, we monitored the protein level of all four complexes of
the mitochondrial respiratory chain and the ATP synthase to
evaluate the results of the expression of mitochondrial target genes.
Incubation of adipocytes with BMP7 during differentiation led to
significantly enhanced mitochondrial protein level (1.6fold), while
FNDC5 and irisin had no effect (Figure 4E, F).
In order to assess the potential induction of genes by FNDC5
and irisin which are different from those previously measured
(Figure 5), we performed a microfluidic card TaqMan gene
Figure 4. BMP7 activates the brite fat gene program in human adipocytes, but not FNDC5 and irisin. Isolated preadipocytes from
human subcutaneous preadipocytes of different donors were differentiated in the presence of 50 ng/ml BMP7, 200 ng/ml FNDC5 (Abnova), 200 ng/
ml FNDC5 (Phoenix) and 60 ng/ml irisin (Phoenix). (A) Relative gene expression of PPARc, UCP1, TCF21 and ZIC1 was measured by qRT-PCR after 12–14
days of differentiation. All expression data were normalized to actin; n$4; ***p,0.001. (B) PGC1b and CYCS mRNA expression was assessed by using
microfluidic card TaqMan gene expression assay, n $4, *p,0.05, **p,0.01. (C) Relative gene expression of CD137 was measured by qRT-PCR on day 0
of differentiation; n = 12; ***p,0.001. (D) The increase of UCP1 and PPARc expression in six individual donors was compared after BMP7 and FNDC5
(Abnova) incubation, respectively. Preadipocytes with high CD137 expression showed a more robust activation of UCP1 compared to PPARc after
BMP7 incubation. (E) Cell lysates were analysed by immunodetection using an oxidative phosphorylation antibody cocktail. A representative blot is
shown. (F) Signal intensities of all complexes of the oxidative phosphorylation were quantified, summed up and normalized to ß-actin, n = 3–5,
*p,0.05. (A-F) White bars, control; black bars, BMP7; horizontally hatched bar, FNDC5 (Abnova), diagonally hatched bar, FNDC5 (Phoenix); crossed
bar, irisin. Data are presented as mean values 6 SEM.
doi:10.1371/journal.pone.0073680.g004
Irisin Has No Effect in Humans
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expression assay including 37 genes associated with adipocyte
differentiation or browning. Several genes were upregulated by
incubation with BMP7 during differentiation including adiponec-
tin (ADIPOQ), C/EBPa, FABPB4, leptin (LEP), and perilipins
(PLIN1, 2, 4 and 5) (Figure 5A). None of these genes were
differentially regulated by FNDC5 or irisin. Genes that were not
regulated by BMP7, FNDC5 and irisin are presented in figure 5B.
Discussion
Targeting irisin and its downstream signaling pathways might
represent an interesting strategy to increase energy expenditure in
humans and to combat obesity by inducing browning of white AT.
Due to a high homology between the murine and human DNA
sequence, it has been speculated that translation from the mouse
model to a human therapeutic approach is possible. Bostro¨m et al.
stated that the cleaved and released part of FNDC5, the hormone
irisin, is highly conserved and identical in all mammalian species
sequenced [21]. Indeed, the FNDC5 gene is well conserved
between organisms with one exception reported here, namely a
mutation in the start codon of the human gene.
Examining the human genomic sequence revealed that the start
from UniProt entry FNDC5/Q8NAU1 (full-length protein as
described by Bostro¨m et al. [21]) is not matched by an ATG codon
and that the upstream conserved ATG of other species is mutated
to an ATA codon in humans. Ivanov et al. performed an algorithm
based analysis of the 59-UTRs of human GenBank RefSeq
mRNAs to find non-ATG start codons in humans [25]. They used
sequences 59 of the annotated start-codon and compared these to
other vertebrate sequences. In this bioinformatic analysis FNDC5
ranks high in their list, as the 59 human amino acid sequence is
almost identical to that in mouse.
Nevertheless, Kozak et al. have shown the presence of ATA
causes low translation efficiency [26]. ATG hairpin program
predicted no eligible stem-loop structure or hairpin for human
FNDC5. These hairpin structures could increase the translation
efficiency by slowing down the scanning process as helicases need
time to resolve these structures and give the ribosome more time to
misread the codon as an ATG start codon [27]. In higher
eukaryotes non-canonical start sites are rare. A search using
Uniprot and a specialized website that is based on NCBI data for
annotated non-canonical ATA start sites (http://bioinfo.iitk.ac.in),
resulted in only three human genes, which are translated to the
protein level (Q02447, Q15561, Q99594).
Nevertheless, to challenge this bioinformatic analysis, we
monitored the ability of the human transcript to be translated
into protein. Overexpression of human FNDC5 in HEK293 cells
with ATA as start codon provided the conclusive proof on the
protein level. HEK293 cells transfected with the human expression
vector using ATG as start codon produced similar amounts of full-
length protein compared to mouse FNDC5. In contrast, the human
transcript with ATA as start codon resulted in only 1% full-length
protein compared to mouse FNDC5. Instead the downstream in-
frame ATG (represented by the cDNA sequence NP_715637) was
Figure 5. Gene expression analysis of human adipocytes after incubation with BMP7, FNDC5 and irisin. Isolated preadipocytes from
human subcutaneous AT of different donors were differentiated in the presence of 50 ng/ml BMP7, 200 ng/ml FNDC5 (Abnova), and 60 ng/ml irisin
(Phoenix). Gene expression of 40 genes, related to adipocyte differentiation (A) and brite differentiation (B), was assessed by a microfluidic card
TaqMan gene expression assay; n $4, *p,0.05, **p,0.01, ***p,0.001 vs control; n.s., not significant. White bars, control; black bars, BMP7;
horizontally hatched bar, FNDC5; crossed bar, irisin. Data are presented as mean values 6 SEM.
doi:10.1371/journal.pone.0073680.g005
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translated into protein. However, this ATG was used with highly
reduced efficiency. Using this downstream ATG, the protein has
lost the signal peptide, which leads proteins towards the secretory
pathway, and almost 50% of the irisin sequence. Using an
optimized expression system with a strong promoter as described
here is certainly not reflecting the natural situation in human
tissue. Our data support that in humans no or only very low
translation of human FNDC5 mRNA into protein is occurring and
primarily a truncated version without signal peptide is produced.
Consequently, irisin should not be detectable or at rather low
concentrations.
Thus, we suggest that the human FNDC5 gene might be a
transcribed pseudogene that has substantially lost the ability to be
translated into the full-length FNDC5 protein and possibly is
unable to be processed to irisin. As a result, the mutation in the
start codon of the human FNDC5 gene may result in low
translation efficiency and might explain the small release of irisin
observed from primary human myotubes as compared to murine
myotubes.
Physical activity promotes a more oxidative phenotype in
skeletal muscle and is characterized by increased expression of
PGC1a in skeletal muscle [29], which may enhance expression of
FNDC5 [21]. Inducing contractile activity in our in vitro model led
to significantly enhanced secretion of the well-known myokines
interleukin-6 and vascular endothelial growth factor [30].
Although using this protocol led to enhanced PGC1a expression
in human myotubes, this did not result in a significantly enhanced
FNDC5 expression. This EPS model rather reflects a training
model than acute exercise as shown by enhanced MHCI mRNA
level and enhanced mitochondrial content [30]. Similar results
were obtained from two different training cohorts. Neither 10
weeks of interval endurance training nor 11 weeks of strength
training in healthy men resulted in increased FNDC5 mRNA
expression in skeletal muscle biopsies. However, strength training
significantly upregulated the secretion of at least 11 myokines in m.
trapezius such as plasminogen activator inhibitor 1, follistatin-like 1
and secreted protein, acidic and rich in cysteine [32]. Bostro¨m
et al. observed enhanced FNDC5 mRNA levels (2-fold) in a cohort
of older, obese subjects after a 10-weeks protocol of endurance
exercise [21]. However, using gene-chip probe sets Timmons et al.
demonstrated that FNDC5 induction in skeletal muscle occurred
only in highly active elderly subjects compared to sedentary
controls (1.3fold), which were a minority of examined subjects.
Moreover, they failed to confirm increased FNDC5 gene expres-
sion after aerobic exercise in younger subjects [33].
Another study showed that circulating irisin levels were only
slightly increased (about 1.2fold) after 2 or 3 sets of double sprints
after one week and not after 8 weeks of exercise [34]. However,
this study measured circulating irisin levels after exercise in human
plasma by using a commercially available ELISA kit. The reported
irisin levels in human blood samples [34–37] are in conflict to our
notion that human FNDC5 is not translated into full-length
protein due to the non-ATG start codon. We recommend that
these data has to be considered with caution and that available
ELISA/EIA kits have to be reappraised by other methods e.g.
mass spectrometry analysis.
Bostro¨m et al. [21] and Sharma et al. [38] used Western blot
analyses to detect irisin in human and murine serum. The
antibody used by the authors was obtained by Abcam and
specifically detects the C-terminal region of the FNDC5 protein
(the peptide used for immunization/antibody synthesis was
sequenced and is highlighted in Figure 1C). FNDC5 is described
as a transmembrane protein with the C-terminal tail located in the
cytoplasm, whereas the extracellular N-terminal part is supposed
to be cleaved and released as irisin. Thus, an antibody binding to
the C-terminal region of the FNDC5 protein is unlikely to detect
irisin in plasma samples.
A study with heart failure patients determined higher expression
of both PGC1a and FNDC5 in subjects with high aerobic
performance, whereas no correlation was found in patients with
low aerobic performance [39]. Nevertheless, muscle-specific
overexpression of PGC1a in transgenic mice showed a significant
increase in FNDC5 mRNA level [21] which might suggest that a
profound induction of PGC1a is necessary to activate the
downstream target FNDC5. Until now, only Bostro¨m et al. have
reported a robust activation of FNDC5 after exercise in humans as
measured by quantitative real-time PCR in skeletal muscle
biopsies [21].
Exercise enhanced the appearance of putative brown adipocyte
progenitor cells in brown AT [40] and was described as novel
physiological stimulus for browning of visceral fat in mice after
controlled treadmill running [41] and free wheel running [21].
Several lines of evidence have suggested that bone morphogenetic
proteins (BMP) induce adipose cell fate determination in
mammalian cells (reviewed in [42]). BMP7 specifically triggers
commitment of the multipotent mesenchymal cells into the brown
adipocytes lineage, inducing the expression of brown fat-specific
markers such as PRDM16 and UCP1 [7]. Embryos of BMP7
knockout mice exhibit a marked deficiency of brown AT and
nearly complete absence of UCP1 expression while adenoviral-
mediated expression of BMP7 in mice results in significant
increase in brown, but not in white AT and leads to an increase in
energy expenditure [7]. Primary human adipocytes differentiated
in vitro have a low basal level of UCP1 gene expression, as
described for white AT [43]. However, incubation of primary
human preadipocytes with BMP7 during differentiation leads to
an increase in PPARc expression and an even more pronounced
increase in UCP1 and CYCS expression as well as enhanced
mitochondrial content resulting in a brite phenotype of the
adipocytes. Since ZIC1, a marker for classical brown adipocytes
[20], was not altered by incubation with BMP7 and PRDM16 was
barely detectable, the differentiated adipocytes subjected to BMP7
incubation display no classical brown phenotype. In addition,
BMP7 incubation decreased TCF21 mRNA level, a marker for
white adipocytes [20].
Wu et al. isolated adipose progenitor cells from murine
subcutaneous white AT, immortalized the cells, generated clonal
cell lines derived from single cells and analyzed the gene
expression pattern of multiple cell lines after induction of
differentiation and treatment with forskolin [31]. They identified
a distinct pool of progenitors within white AT that can give rise to
cells expressing UCP1 upon an adequate stimulus. These brown-
like or ‘‘brite’’ cells are similar, but not identical, to classical brown
fat cells and express brite-selective genes, including a develop-
mental transcription factor (Tbx1), a component of lipid metabolism
pathways (Slc27a1), as well as molecules known to be important in
immune und inflammatory pathways (CD40 and CD137). Thus,
murine brite cells have a gene expression pattern distinct from
either white or brown AT. CD137 was then used to define primary
brite adipocyte precursors and CD137-high expressing cells
showed substantially elevated expression of UCP1 after incubation
with irisin-Fc and recombinant FNDC5 compared to CD137-low
expressing cells [31]. In our study we observed a ‘britening’ effect
of human adipocytes after incubation with BMP7 with the most
prominent effect in CD137-high expressing cells. However, neither
recombinant FNDC5 nor the cleaved protein irisin triggered a
brite differentiation of adipocytes in CD137-high- or CD137-low-
expressing cells. Our results are supported by data recently
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presented at the Annual Meeting of the American Diabetes
Association by Lee et al. showing that neither FNDC5 nor irisin
induces browning of human and mouse adipocytes [44].
Wu et al. examined the gene expression profile of brown fat
from 11 adult humans and unexpectedly found that the profile was
closer to that of mouse brite cells than to that of mouse classical
brown cells [31]. However, the presence of classical brown AT in
humans has recently been shown by three independent groups
[43,45,46]. The gene expression of classical markers of mouse
brown, brite, and white adipocytes in adult human brown AT
isolated from the supraclavicular region [43] or anatomically
defined neck fat [45] suggests that human brown AT might consist
of both classical brown and recruitable brite adipocytes. In
addition, Lidell et al. provide evidence for an anatomically
distinguishable interscapular brown AT depot in human infants
that consists of classical brown adipocytes [46]. When thinking
about pharmaceutically targeting brown and brite AT as a
therapeutic approach to counteract human obesity it is of
importance to clearly identify the developmental origin of these
tissues in humans. Moreover, Cannon and Nedergaard raised the
question how certain white-like adipocytes, which in general
possess very few mitochondria, suddenly enhance their mitochon-
drial complement during the britening process and from where
these adipocytes originate [47]. These crucial key questions should
be addressed in future studies.
In conclusion, human FNDC5 should be annotated as a
transcribed pseudo-gene that has lost the ability to be effectively
translated into full-length FNDC5 protein. A shorter protein
version is translated only with low efficiency, but this protein has
lost the signal peptide and almost 50% of the irisin sequence.
Could irisin nevertheless be a potential drug in humans if
downstream regulatory pathways might still exist? We observed
no effect of recombinant FNDC5 and irisin on the britening of
primary human adipocytes. Thus, we conclude that the function of
irisin proposed for mice is lost in humans.
Materials and Methods
The study to obtain biopsies from m. vastus lateralis was
approved by the Regional Committee for Research Ethics,
Trondheim, Norway. Written informed consent was obtained
from all participants.
The study to obtain biopsies from m. trapezius was approved by
the Regional Committee for Research Ethics, Oslo, Norway and
written informed consent was obtained from all participants.
The procedure to obtain subcutaneous adipose tissue was
approved by the ethical committee of the Heinrich-Heine-
University, Du¨sseldorf and all the donors provided written
informed consent.
Sequence Alignment
ClustalW was used for multiple alignments. Blast searches were
done using NCBI-BLAST interface. FNDC5 exon 1 sequences
were obtained from ENSEMBL (Exon1_human:
ENSE00001862258; Exon1_gorilla: ENSGGOE00000102667;
Exon1_gibbon: ENSNLEE00000033119; Exon1_rat: EN-
SRNOE00000220327; Exon1_mouse: ENSMUSE00000333154.
The Exon1_chimp had an gap. Therefore this gap was sequenced
internally using 3 independent Chimp genomic DNAs (Exon1_ch-
imp: ENSPTRE00000406642, ENSPTRE00000351668 and se-
quenced by us). All other Exon1 sequences were obtained from
Ensembl. The protein sequences were obtained from Uniprot in
case of the human, mouse and rat sequences (FNDC5_HU-
MAN_o: Q8NAU1 old version until 2012_08; FNDC5_HU-
MAN_c: Q8NAU1 current version since 2012_08;
FNDC5_mouse: Q8K4Z2; FNDC5_rat: Q8K3V5). The gorilla
and gibbon sequences were obtained from ENSEMBL
(FNDC5_gorilla: ENSGGOP00000009792; FNDC5_gibbon EN-
SNLEP00000003686), the chimp sequence was a combination of
ENSEMBL and in-house sequence. Single nucleotide polymor-
phism data were obtained from NCBI and ENSEMBL. UNI-
PROT was searched for annotated non-canonical start sites in
human proteins. The search for hairpin structures close to the start
codon was done with the public tool AUG_hairpin (http://
wwwmgs.bionet.nsc.ru/mgs/programs/aug_hairpin/).
Overexpression of FNDC5 Constructs in HEK293 Cells
HEK293 cells were seeded in six-well plates coated with
fibronectin at a density of 46105 cells/well in DMEM, high
glucose containing 10% (vol./vol.) fetal calf serum and 16 Pen/
Strep 24 h prior to transfection. The HEK293 cells were
transfected with human or mouse FNDC5 cloned into pcDNA5-
FRT-TO_cEGFP expression vector (Figure S5). An additional
vector was generated by single point mutation in the naturally
occurring start codon ATA of human FNDC5 to ATG.
Transfection of HEK293 cells with 2 mg DNA was done as
described by the manufacturer using jetPRIME reagent (Polyplus).
After 24 h cells were lysed in an ice-cold lysis buffer containing
50 mmol/l Tris/HCl (pH 7.4), 1% (vol./vol.) NP-40, 0.25% (vol./
vol.) sodium-deoxycholate, 150 mmol/l NaCl, 1 mmol/l EDTA,
1 mmol/l Na3VO4, and protease inhibitor cocktail (Roche).
Deglycosylation of glycoproteins in the cell lysates using PNGase
F was performed as specified by the manufacturer (New England
Biolabs). Samples were analysed via SDS-PAGE and immuno-
blotting using standard methods. Antibodies against irisin/FNDC5
were from Phoenix Pharmaceuticals and against GFP from
Rockland.
Culture of Primary Human Skeletal Muscle Cells
Human skeletal muscle cells from five healthy donors (three
males, 16, 21 and 47 years old; two females, 33 and 37 years old)
were supplied as proliferating myoblasts (PromoCell, Lonza and
Tebu). For an individual experiment, myoblasts were seeded in
six-well culture dishes at a density of 16105 cells/well and cultured
to near-confluence in a-modified Eagle’s medium (aMEM)/Ham’s
F-12 medium containing skeletal muscle cell growth medium
supplement (PromoCell). The cells were then differentiated in
aMEM containing 2% (vol/vol) horse serum (Gibco) until day 5 of
differentiation and followed by overnight starvation in aMEM
without serum.
Culture of Murine C2C12 Cells
C2C12 myoblasts were seeded in six-well culture dishes at a
density of 16105 cells/well and cultured to near-confluence in
DMEM, high glucose containing 10% (vol./vol.) fetal calf serum
(FCS). The cells were then differentiated in DMEM containing
2% (vol./vol.) horse serum until day 5 of differentiation and
followed by overnight starvation in DMEM without serum.
Detection of Irisin
Supernatants of primary human and C2C12 myotubes were
collected for 24 h in serum free medium. The medium was
centrifuged at 1,100 rpm for 5 min and afterwards concentrated
using centrifugal filter devices with a cut off of 3 kDa (Millipore).
Irisin protein levels in concentrated supernatants were quantified
using EIA kit from Phoenix Pharmaceuticals according to the
manufacturers instructions.
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Electrical Pulse Stimulation
EPS was applied to fully differentiated myotubes in six-well
dishes using a C-Dish combined with a pulse generator (C-Pace
100; IonOptix). The instrument emits bipolar stimuli to the carbon
electrodes of the C-dish, which are placed in the cell culture
medium. The human skeletal muscle cells were stimulated (1 Hz,
2 ms, 11.5 V) for 24 h after overnight starvation in serum-free
aMEM [30]. The medium was changed directly before stimula-
tion.
Human Interval Training Study (Endurance Training)
Skeletal muscle biopsies were obtained from a subgroup of 6
untrained men (aged 40.862.1 years; BMI: 26.161.8 kg/m2)
before and after 10 weeks of aerobic interval training
(NCT00839579) [48]. Shortly, the participants performed endur-
ance training on a treadmill 4 6 4 min intervals at ,90% of
maximum heart frequency (HRpeak) with 3 min active recovery
period at,70% of HRpeak between each interval, 3 times weekly.
Needle biopsies of m. vastus lateralis of fasting subjects were obtained
at least 4 days after the last training session. Total RNA was
extracted using Trizol and RNeasy Mini kit (Qiagen).
Human Strength Training Study
Seven healthy, untrained men (aged 28.364.2 years; BMI:
23.162.4 kg/m2) participated in a strength-training program 3
times weekly for 11 weeks [32,49]. Before study start and at least
48 h after the last training session, needle biopsies were obtained
from m. trapezius. Total RNA was prepared based on a modified
version of the method described by Chomczynski and Sacchi [50].
Adipocyte Culture and Immunodetection
Subcutaneous AT was obtained from healthy lean or moder-
ately overweight women (aged 40.464.2 years, BMI 28.061.1,
n = 17) undergoing plastic surgery. Preadipocytes were isolated by
collagenase digestion of AT as previously described by our group
[51]. Isolated cell pellets were resuspended in basal medium
(DMEM/F12 medium supplemented with 14 nmol/l NaHCO3,
33 mmol/l biotin, 17 mmol/l D-panthothenic-acid and 10%
(vol./vol.) FCS, pH 7.4), seeded in six-well plates and maintained
at 37uC with 5% CO2. After cells were grown until confluence,
cultures were washed and further incubated in an adipocyte
differentiation medium (basal medium supplemented with 66 nM
insulin, 1 nM triiodo-L-thyronine, 100 nM cortisol, 10 mg/ml
apo-transferrin, 50 mg/ml gentamycin) for 14 days. Medium was
changed every 2–3 days with addition of 5 mM troglitazone for the
first three days. Adipocytes were incubated with 50 ng/ml BMP7
(R&D systems), 200 and 1000 ng/ml FNDC5 (Abnova and
Phoenix), 60 and 600 ng/ml irisin (Phoenix), and 60 and 600 ng/
ml irisin (Cayman Chemical) during differentiation, respectively.
Immunoblotting of lysates was performed as described in [30].
Oxphos antibody cocktail was provided by MitoSciences.
RNA-isolation and Quantitative Real-time PCR
Cells were lysed by Tripure (Roche Applied Science), RNA was
isolated and reverse-transcribed using kits (RNeasy Mini, Omnis-
cript Reverse Transcription, Qiagen) according to the manufac-
turer’s instructions. Gene expression was determined by quanti-
tative real-time PCR using primers as described in Table S1 and
GoTaq qPCR Master Mix (Promega) with 0.016 to 20.00 ng
cDNA on a cycler (Step One Plus; Applied Biosystems).
Expression of the investigated genes was normalised to actin or
GAPDH and analysed via the DDCt method.
For human muscle biopsy samples, total RNA was reversely
transcribed into cDNA on a Gene Amp PCR 9700 thermal cycler
with the High Capacity cDNA reverse Transcription kit (Applied
Biosystems Foster City, CA). Quantitative real-time PCR was
performed with reagents and instruments from Applied Biosystems
in the 96-well format using a 7900 HT Fast instrument and the
SDS 2.3 software (Applied biosystems) [52]. Predeveloped primers
and probe sets (TaqMan assays, Applied Biosystems) were used to
analyze mRNA levels of FNDC5 (Hs00401006_m1) and large
ribosomal protein P0 (RPLP0, Hs99999902_m1). Relative target
mRNA expression levels were calculated as 22[Ct(target)-Ct(RPLP0))],
thereby normalizing data to endogenous control RPLP0. For
expression studies in human tissues the human FNDC5 probe set
Hs00401006 from Life Technologies Corporation was used. Total
RNA samples from different human tissues were purchased from
Clontech Laboratories, Inc.
Microfluidic Card TaqMan Gene Expression Assay
RNA integrity was tested on an Agilent 2100 Bioanalyzer using
Agilent RNA Nano chips. Only RNAs with a RIN score of 7.5 or
higher were used for analysis. Synthesis of cDNA was done from
0.5 mg of each total RNA preparation in a volume of 20 ml with
the Quantitect Reverse Transcription Kit from Qiagen according
to the manufacturer’s instructions. Thermal cycling of the PCR
reactions was done in microfluidic cards on a ViiA7 Real Time
PCR 384 well cycler and fluorescence plate reader from Applied
Biosystems (see Table S2 for details on used gene specific TaqMan
assays).
Statistics
Data are expressed as mean 6 SEM. One-way ANOVA (post-
hoc test: Tukey’s multiple comparison test) and unpaired student’s
t-test were used to determine statistical significance. All statistical
analyses were done using GraphPad Prism 5 considering a p-value
of less than 0.05 as statistically significant.
Supporting Information
Figure S1 Genotyping of human FNDC5 exon 1 se-
quence. Source of mRNA for 59-RACE was (A) human skeletal
muscle and (B) human cerebellum. Tissue samples were obtained
from Clontech. Identified sequences with bp 55–91 of human
FNDC5 variant 2 (NM_153756) and variant 3 (NM_001171940).
(TIF)
Figure S2 Alignment of two Ref_Seq cDNAs (NM
001171940.1 and NM_153756.2) and 20 expressed se-
quence tags sequences. The alignment covers the mutated
start ATG to ATA codon and the CTC codon in purple that
should be the start ATG, if the FNDC5 protein sequence
published by Bo¨strom et al. [21] is forced to match the exon1
sequence.
(TIF)
Figure S3 cDNA sequence showing the non-Kozak start
ATG of NP_ 715637/NM_153756. The 3 partial Kozak ATGs
and the common stop codon (in yellow) for these 3 uORFs are
boxed.
(TIF)
Figure S4 Secondary structure of FGF2 and human
FNDC5 mRNA. Using a program for prediction of a
downstream hairpin which potentially increases initiation of
translation at start AUG codon in a suboptimal context showed
a positive result for FGF2 (A) and no result for FNDC5 (B).
(TIF)
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Figure S5 Human FNDC5 mRNA expression levels in
different human tissues. The expression was measured by
qRT-PCR and expressed relative to mRNA levels of GAPDH,
shown are means +/2 SD from two measurements. Total RNA
samples pooled from several donors were purchased from
Clontech Laboratories, Inc.
(TIF)
Figure S6 Vectors maps of ATA-hFNDC5-GFP (A) and
ATG-hFNDC5-GFP (B).
(TIF)
Figure S7 Quantification of GFP fluorescence in
HEK293 cells. (A) In 96 well plate format HEK293 cells were
seeded at a density of 26104/well and transiently transfected with
0.05 mg of the indicated expression vector using jetPRIME
reagent. 24 h later cells were visualized using 1006magnification
on an inverted fluorescence microscope. (B) Quantification of GFP
signal was measured with an Ultra Evolution Tecan at 485 and
520 nm. Data are presented as mean values 6 SEM.
(TIF)
Figure S8 Isolated preadipocytes from human subcuta-
neous preadipocytes of different donors were differen-
tiated in the presence of 50 ng/ml BMP7, 200 and
1000 ng/ml FNDC5 (Abnova), 60 and 600 ng/ml irisin
(Phoenix) and 60 and 600 ng/ml irisin (Cayman Chem-
ical). (A, B) Relative gene expression of PPARc (A) and UCP1 (B)
was measured by qRT-PCR after 12–14 days of differentiation.
All expression data were normalized to the mRNA level of actin;
n = 5–6 (for treatment with irisin provided by Cayman Chemical
n = 3); ***p,0.001. (C) Cell lysates were analysed by immunode-
tection using an oxidative phosphorylation antibody cocktail.
Signal intensities of all complexes of the oxidative phosphorylation
were quantified and normalized to ß-actin, n = 3–5, **p,0.01.
(TIF)
Table S1 Overview of used primers.
(DOCX)
Table S2 Gene symbols and corresponding TaqMan
assay IDs provided by Applied Biosystems used for
microfluidic card real-time PCR analysis.
(DOCX)
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